Cognitive-behavioural therapy combined with music therapy for chronic fatigue following Epstein-Barr virus infection in adolescents: a feasibility study. — CFSMEATLAS
Cognitive-behavioural therapy combined with music therapy for chronic fatigue following Epstein-Barr virus infection in adolescents: a feasibility study.
Malik, Sadaf, Asprusten, Tarjei Tørre, Pedersen, Maria et al. · BMJ paediatrics open · 2020 · DOI
Quick Summary
This study tested whether combining two types of therapy—cognitive-behavioral therapy (which helps change thought patterns and behaviors) and music therapy—could help adolescents recover from prolonged fatigue that started after an Epstein-Barr virus infection. Over 15 months, researchers compared 21 young people who received the combined therapy with 22 who received standard care. The therapy was safe and well-tolerated, and there were hints that it might help with symptom recovery, though the study was too small to prove effectiveness.
Why It Matters
ME/CFS and postinfectious fatigue remain poorly treated, and evidence-based psychological interventions remain controversial in this population. This feasibility study is the first to examine whether combined CBT and music therapy is tolerable and potentially beneficial specifically in postinfectious fatigue, rather than in heterogeneous ME/CFS populations. If confirmed in a larger trial, such a combined approach might offer a safe, multimodal option for adolescents with debilitating postinfectious fatigue.
Observed Findings
Seven participants (16%) discontinued during the first 3 months, reducing the intervention group from 21 to 15 and leaving 36 evaluable at 3-month follow-up.
At 3 months, physical activity (steps/day) tended to decrease in the intervention group by 1,158 steps (95% CI −2,642 to 325); the clinical significance and direction of this change is unclear.
At 3 months, postexertional malaise scores tended to improve (decrease by 0.4 points, 95% CI −0.9 to 0.1) in the intervention group.
At 15-month follow-up, 62% of the intervention group had recovered versus 37% of the control group—a nonsignificant trend.
No harmful effects were reported, and compliance with scheduled appointments was high among those who remained in the study.
Inferred Conclusions
Combined CBT and music therapy for postinfectious chronic fatigue following EBV in adolescents is feasible to deliver and acceptable to participants, with good session attendance and no safety signals.
There are preliminary signals of symptomatic benefit and higher recovery rates in the intervention group, particularly at 15-month follow-up, though these trends are not statistically significant and require confirmation in a larger, adequately powered trial.
The authors recommend proceeding to a full-scale randomized controlled trial to definitively test efficacy.
Remaining Questions
What is the optimal duration, frequency, and structure of combined CBT and music therapy for postinfectious fatigue in adolescents?
What This Study Does Not Prove
This study does not prove that CBT plus music therapy is effective for postinfectious fatigue; it was explicitly underpowered for efficacy, and the observed differences in activity and symptom scores were not statistically significant. The high early dropout rate (7/43 by 3 months) raises questions about long-term acceptability and adherence. The study also cannot determine which component (CBT or music therapy) drove any observed benefit, nor whether benefits persist beyond 15 months.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Which component—CBT, music therapy, or the combination—accounts for observed improvements, if any?
Why did activity (steps/day) tend to decrease in the intervention group, and does this reflect deconditioning, measurement error, or a compensatory reduction after therapy?
Do benefits persist beyond 15 months, and what is the relapse rate in the intervention versus control group after longer follow-up?